Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license
Fierce Pharma
FEBRUARY 24, 2023
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Fierce Pharma
FEBRUARY 24, 2023
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18
Fierce Pharma
NOVEMBER 20, 2023
s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. s drug pricing policy, the pharma industry has secured an improved government spending deal. After blasting the U.K.’s After blasting the U.K.’s
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
FEBRUARY 7, 2023
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08
Fierce Pharma
MAY 2, 2023
Gilead, US government set for courtroom showdown over PrEP drug patents esagonowsky Tue, 05/02/2023 - 08:50
Advertiser: ZoomInfo
However, as a company, sales stack, and database grow, it becomes difficult to uphold structure and governance to keep a CRM up-to-date. When used effectively, a CRM can be the lifeblood of your sales team – keeping everyone organized, efficient, and at peak productivity. The result? Less organization, more confusion, and fewer deals closed.
Fierce Pharma
JULY 9, 2024
government appealed Gilead's prior win in the fight. . | As Gilead Sciences tussles with a web of HIV med litigation, a case tied to patents for prevention regimens of Truvada and Descovy is not quite settled. Late last week, the U.S.
Fierce Pharma
FEBRUARY 29, 2024
million to the federal government, which had been investigating the marketing of opioid Opana ER.
Fierce Pharma
SEPTEMBER 23, 2024
Ahead of a Senate hearing centered on high prices for Novo Nordisk’s in-demand semaglutide medications, lawmakers are pressing the government to use its “march-in” rights and allow generic versions | In a letter to HHS secretary Xavier Becerra, several lawmakers urged the government to allow generic licenses for Novo's GLP-1 medicines Ozempic (..)
Fierce Pharma
SEPTEMBER 5, 2023
Despite scoring a number of federal contracts in recent years, it’s lights out for government-backed rescue autoinjector maker AktiVax. AktiVax, also known as Aktiv Pharma Group, informed the state of Colorado that “the company must shut down substantially all of its operations,” citing “unexpected circumstances.”
Fierce Pharma
MAY 9, 2023
Gilead notches trial win in high-stakes HIV patent case against US government zbecker Tue, 05/09/2023 - 16:24
Fierce Pharma
MAY 30, 2024
The United States Department of Health and Human Services has expanded its avian flu pandemic preparedness partnership with CSL Seqirus, lining up the vaccine specialist to
Fierce Pharma
MARCH 13, 2024
As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Washington, D.C. |
Fierce Pharma
APRIL 11, 2024
government is accusing Regeneron of deliberately using an unusual method to overcharge Medicare for the company’s popular eye drug Eylea. | government is accusing Regeneron of deliberately using an unusual method to overcharge Medicare for the company’s popular eye drug Eylea.
pharmaphorum
NOVEMBER 29, 2024
UK government commits to first men's health strategy Phil.Taylor Fri, 29/11/2024 - 08:45 Bookmark this
Fierce Pharma
SEPTEMBER 18, 2024
Authors: | Unlock the potential of patient support data with effective information governance. Manage risks, ensure compliance, and drive innovation for better patient outcomes.
Fierce Pharma
JUNE 7, 2023
As pharma supply chain problems drag on, a shortage of key cancer drugs has afflicted a large number of treatment centers and many patients. | The National Comprehensive Cancer Network's recent survey shows that nearly all of the treatment centers it polled are facing a carboplatin shortage.
MedCity News
MARCH 31, 2023
Proper data governance is essential to ensure the efficient and accurate operation of an organization. It involves creating static rules, dynamic management processes and a comprehensive set of business objectives which must be met to protect the integrity of data within the system.
Fierce Pharma
FEBRUARY 2, 2024
The strategy includes 11 key growth brands and a continued emphasis on business development.
Fierce Pharma
AUGUST 8, 2024
government. | Following the commercial launch of Bavarian Nordic’s smallpox/mpox vaccine Jynneos earlier this year, the Danish company has locked up yet another supply agreement with the U.S. The Biomedical Advanced Research and Development Authority (BARDA) is handing Bavarian Nordic $156.8
Fierce Pharma
JULY 2, 2024
With four contract modifications totaling more than $250 million, the government is leveling up its agreements with long-time medical countermeasures supplier Emergent BioSolutions. | government's medical countermeasures stockpile.
Fierce Pharma
OCTOBER 4, 2023
government is winding down its distribution of COVID-19 countermeasures. | The government will wind down its Lagevrio distribution ahead of the transition, the Administration for Strategic Preparedness and Response said. As long expected, the U.S.
World of DTC Marketing
JUNE 5, 2021
The post Obesity represents a catastrophic failure of government policy, public health, and medicine. This includes looking at obesity as a disease, viewing it in a similar manner to how employers see chronic diseases, such as diabetes or heart disease. appeared first on World of DTC Marketing.com.
Fierce Pharma
MARCH 26, 2024
Maryland non-profit Caring Cross has unveiled a partnership with the Brazilian government that's designed to provide access to advanced cell and gene therapies for diseases like leukemia, lymphoma | Maryland nonprofit Caring Cross has unveiled a partnership with the Brazilian government which is designed to provide access to advanced CAR-T and (..)
Pharmaceutical Technology
NOVEMBER 29, 2024
The government said that men are less likely than women to seek medical help, particularly for mental health issues.
Fierce Pharma
APRIL 1, 2024
government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. government to stockpile and distribute Jynneos, Bavarian Nordic is launching the mpox vaccine into the commercial market. After years relying on the U.S. After years relying on the U.S.
Fierce Pharma
SEPTEMBER 5, 2023
government as a reaction to the Inflation Reduction Act (IRA). | Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S. government as a reaction to the Inflation Reduction Act. Add Novartis to the list of biopharma giants that have filed lawsuits against the U.S.
Fierce Pharma
JULY 12, 2023
Merck is bringing more heat in its battle against drug price negotiation provisions in the Inflation Reduction Act (IRA), filing Tuesday in federal court in Washington, D.C. Merck is bringing more heat in its battle against drug price negotiation provisions in the Inflation Reduction Act (IRA), filing Tuesday for a decision without a trial.
Fierce Pharma
AUGUST 20, 2024
government. For years, Teva has been defending itself against allegations that it used illegal Medicare co-pay schemes to fuel sales of its multiple sclerosis drug Copaxone. | The new lawsuit, filed in a Kansas court, comes as Teva defends against similar allegations made by the U.S.
Pharmaceutical Technology
DECEMBER 21, 2022
Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. The post Moderna and UK government sign deal to establish mRNA facility appeared first on Pharmaceutical Technology.
Fierce Pharma
DECEMBER 12, 2023
Over the past several years, drug shortages have vexed doctors and patients on both sides of the Atlantic, prompting lawmakers and government agencies to take action in both Europe and the U.S. Tuesday, the European Medicines Agency laid out a list of more than 300 critical generic drugs that could fall prey to future shortages.
Fierce Pharma
JULY 6, 2023
His most recent push is to mandate price caps for drugs that were developed with the help of government funding. Bernie Sanders, I-Vermont—a longtime opponent of Big Pharma—has become even more ubiquitous in his efforts to reduce drug prices.
Fierce Pharma
APRIL 30, 2024
government requiring drugmakers to negotiate with Medicare on drug pricing. Biopharma companies and industry lobbying groups are striking out in their legal efforts to challenge price-cutting measures in the Inflation Reduction Act. | And AstraZeneca has filed its challenge to a federal appeals court following a similar defeat.
MedCity News
APRIL 4, 2024
In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities. The post Boutique Healthcare Investment Event in Chicago Highlights AI, Government Funding, Value-Based Care.
Fierce Pharma
FEBRUARY 6, 2024
Federal Trade Commission supports a draft guidance that would allow drug pricing be factored into consideration of the government's march-in rights. As the U.S. | And the antitrust watchdog is advocating for further scrutiny around "patent thickets" to complement the march-in provision.
Fierce Pharma
FEBRUARY 23, 2024
This week on “The Top Line,” we explore the impact of environmental, social and governance measures, commonly known as ESG, on the pharmaceutical industry. | This week on "The Top Line," we explore the impact of environmental, social, and governance measures, commonly known as ESG, on the pharmaceutical industry.
Fierce Pharma
JUNE 24, 2024
government has selected Pfizer to supply 5 million doses of its RSV shot Abrysvo over the next two years. . | After losing round one of its respiratory syncytial virus (RSV) vaccine bout with GSK, Pfizer is rallying. And what better way to do it than to win a major contract in your rival’s home country?
Fierce Pharma
JULY 18, 2024
government near the deadline of their drug price talks under the Inflation Reduction Act, Novartis CEO said the cost cuts “might be manageable” in the short term for the firm’s first few products to be included. As biopharma companies and the U.S. | As biopharma companies and the U.S.
Fierce Pharma
APRIL 3, 2024
Medicare drug price negotiations under the Inflation Reduction Act are steadily progressing after drugmakers recently submitted their counteroffers to the government's initial pricing proposals.
Fierce Pharma
FEBRUARY 21, 2024
A federal judge in New Jersey agreed to let Bristol Myers Squibb, Novo Nordisk, Novartis and J&J present oral arguments together in their bid to challenge the government's new Medicare negotiations framework.
European Pharmaceutical Review
MAY 17, 2024
Yet, without the assumption of high trust in the data with strong data governance, the risks can become intolerably high as companies’ dependency on the flow of good data broadens. SG: Another preconception is that data quality governance is an IT / data management concern first and foremost. So, what’s the best way forward?
Fierce Pharma
FEBRUARY 1, 2024
And today, the government is sending out its first round of offers on affected drugs. Despite litigation and denouncements from the biopharma industry, Medicare price negotiations under the Inflation Reduction Act are rolling on.
Fierce Pharma
AUGUST 8, 2024
It was part of a dizzying scale up when the company—fueled by government funding—was awash with outsized expectations. Novavax purchased the site in May of 2020 for $167 million with the intent of it producing more than 1 billion doses annually there.
Fierce Pharma
AUGUST 7, 2024
Vertex and CRISPR Therapeutics are making inroads by securing a thumbs up from England’s National Institute for Health and | The cost-effectiveness regulator recommended government funding for the groundbreaking gene-editing therapy in one of its two approved indications.
Fierce Pharma
JUNE 7, 2023
On Wednesday, the government unveiled a two-year pilot program that will allow Novo Nordisk’s Wegovy to be given to more overweight participants, even though the treatment has yet to be launched there. The rush to provide revolutionary weight-loss drugs to obese patients has reached the U.K. |
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content